Affiliation:
1. Predictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA
2. Division of Cardiology Tufts Medical Center Boston MA
3. Department of Dental Public Health Faculty of Dentistry King Abdulaziz University Jeddah Saudi Arabia
Abstract
Background
While many clinical prediction models (
CPM
s) exist to guide valvular heart disease treatment decisions, the relative performance of these
CPM
s is largely unknown. We systematically describe the
CPM
s available for patients with
valvular heart disease
with specific attention to performance in external validations.
Methods and Results
A systematic review identified 49
CPM
s for patients with
valvular heart disease
treated with surgery (n=34), percutaneous interventions (n=12), or no intervention (n=3). There were 204 external validations of these
CPM
s. Only 35 (71%)
CPM
s have been externally validated. Sixty‐five percent (n=133) of the external validations were performed on distantly related populations. There was substantial heterogeneity in model performance and a median percentage change in discrimination of −27.1% (
interquartile range
, −49.4%–−5.7%). Nearly two‐thirds of validations (n=129) demonstrate at least a 10% relative decline in discrimination. Discriminatory performance of Euro
SCORE II
and Society of Thoracic Surgeons (2009) models (accounting for 73% of external validations) varied widely: Euro
SCORE II
validation c‐statistic range 0.50 to 0.95;
Society of Thoracic Surgeons
(2009) Models validation c‐statistic range 0.50 to 0.86. These models performed well when tested on related populations (median related validation c‐statistics: Euro
SCORE II
, 0.82 [0.76, 0.85];
Society of Thoracic Surgeons
[2009], 0.72 [0.67, 0.79]). There remain few (n=9) external validations of transcatheter aortic valve replacement
CPM
s.
Conclusions
Many
CPM
s for patients with
valvular heart disease
have never been externally validated and isolated external validations appear insufficient to assess the trustworthiness of predictions. For surgical valve interventions, there are existing predictive models that perform reasonably well on related populations. For
transcatheter aortic valve replacement (CPM
s additional external validations are needed to broadly understand the trustworthiness of predictions.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献